{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
nonoxynol-9
to a specific field?
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2006)
Source URL:
First approved in 2006
Source:
21 CFR 348
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2006)
Source URL:
First approved in 2006
Source:
21 CFR 348
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT02542462: Phase 4 Interventional Completed Intussusception
(2015)
Source URL:
First approved in 2006
Source:
BLA125122
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT02542462: Phase 4 Interventional Completed Intussusception
(2015)
Source URL:
First approved in 2006
Source:
BLA125122
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 356
(2005)
Source URL:
First approved in 2005
Source:
21 CFR 356
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT01659996: Phase 4 Interventional Completed Meningitis
(2012)
Source URL:
First approved in 2005
Source:
BLA125089
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2009)
Source URL:
First approved in 2005
Source:
21 CFR 352
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT00282295: Phase 4 Interventional Completed Acellular Pertussis
(2006)
Source URL:
First approved in 2005
Source:
BLA125089
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
MENOW SUNSCREEN by SHANTOU QIWEI INDUSTRY CO.,LTD
(2025)
Source URL:
First approved in 2005
Source:
21 CFR 352
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
M020
(2019)
Source URL:
First approved in 2005
Source:
21 CFR 347
Source URL:
Class:
STRUCTURALLY DIVERSE